VISK — Viskase Holdings, Inc.

—
OTC · Health Care · Biotechnology · CIK 727510 ·
Last close
$4.43
Market Cap
$63.49M
52W High
$8.55
52W Low
$0.02
ADV30
937
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 95,279,000 8,503,000 -2,848,000 -6,403,000 427,470,000 7,747,000 250,150,000
Mar 2026 86,537,000 9,000,000 -3,970,000 -6,689,000 428,874,000 28,619,000 238,190,000
Dec 2025 81,727,000 4,850,000 -9,879,000 -18,679,000 402,142,000 9,217,000 257,782,000
Sep 2025 91,162,000 5,865,000 -8,055,000 -12,984,000 399,836,000 7,692,000 250,521,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-3,446,000
Investing CF
$-36,997,000
Financing CF
$63,347,000
CapEx
$-36,997,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-7.43
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-30,035,000
Inventory
$100,337,000
Receivables
$69,981,000
ST Investments
—
EBIT TTM
$-35,149,000
Pretax Income TTM
$-45,063,000
Interest Exp TTM
$9,914,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$353,673,984
EBITDA
$-1,512,000
Free Cash Flow
$-32,188,376
Enterprise Value
$206,461,392
Total Cash
$7,747,000
Total Debt
$154,923,008
Shares Out
14,331,620
Trailing EPS
$-2.59
Book Value
$12.49
ROE
-22.7%
ROA
-2.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 364,356,000 -17,268,000 -65,494,000 402,142,000 257,782,000 145,843,000 12,998,000
Dec 2024 403,775,000 17,800,000 -5,360,000 — — — 3,369,000
Dec 2023 445,984,000 39,721,000 13,506,000 — — — 44,165,000

TTM Snapshot

Revenues TTM
$176,668,000
NetIncome TTM
$-13,646,000
OpCashFlow TTM
—
Assets (Latest)
$424,483,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
CSBR CHAMPIONS ONCOLOGY, INC. $63.91M $4.59 —
NMRA Neumora Therapeutics, Inc. $62.85M $0.33 —
CRDF Cardiff Oncology, Inc. $65.85M $0.85 —
ATRA Atara Biotherapeutics, Inc. $66.22M $6.50 —
CGTX COGNITION THERAPEUTICS INC $59.90M $0.63 —

Recent Insider Activity

No insider activity indexed for this ticker.